CD4+-T-cells are a central link in the adaptive immune system with implications for opportunistic and viral infections, previously demonstrated for MM patients receiving traditional chemotherapy and bortezomib (6, 26, 28, 30). This evidence concerns the gene CD4 and Miyoshi myopathy.